Note: Ingredients listed on restricted chemical lists
EC/CAS
208-764-9/541-02-6
Name of the chemical
D5
Concentration
>=0,1-<1
EC/CAS
200-663-8/67-66-3
Name of the chemical
Chloroform
Concentration
>=0,1-<1
EC/CAS
209-136-7/556-67-2
Name of the chemical
D4
Concentration
>=0,025-<
General Information
Version
2.1
Revision date
2025-11-11
Product name
Aftovaxpur Injection solution
Product Synonyms
Aftovaxpur® Injection solution with: Inactivacted Foot & Mouth disease virus, 8 virus strains
1.2.1 Relevant identified uses
Veterinary product
1.2.2. Uses advised against
Safety Data Sheet only for the professional user., For veteri- on use nary use only, Refer to the product insert for complete instruc- tions on usage
Emergency telephone
+498007790900, +1 703-527-3887, +49800 1817059
Icons in SDS
Company Information
company name
Boehringer Ing. Pharma GmbH & Co. KG
e-mail address of the competent person responsible for the Safety Data Sheet
EHS-Services@Boehringer-Ingelheim.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H412
Hazard statements
Code
Statements
H412
Harmful to aquatic life with long lasting effects
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
Signal word
Danger
Hazard statements
H412 Harmful to aquatic life with long lasting effects. EUH441 Strongly accumulates in the environment and living organisms including in humans.
Prevention
P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P273 Avoid release to the environment.
Response
P391 Collect spillage.
Disposal
P501 Dispose of contents/ container to an approved waste disposal plant.
Hazardous Ingredients
Decamethylcyclopentasiloxan (D5)
2.3 Other hazards
This substance/mixture contains components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB).
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regu- lation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher. This drug is not subject to the labelling requirements under the Globally Harmonized System (GHS) The pharmacological effect of the medicament has to be considered (see package leaflet).
2.1 Classification of the substance or mixture
Classification (REGULATION (EC) No 1272/2008) Long-term (chronic) aquatic hazard, Cat- H412: Harmful to aquatic life with long lasting ef- egory 3 fects. Persistent, bioaccumulative and toxic EUH440: Accumulates in the environment and living organisms including in humans. Very persistent and very bioaccumulative EUH441: Strongly accumulates in the environment and living organisms including in humans.
